Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
J Theor Biol. Author manuscript; available in PMC 2010 August 9.
Published in final edited form as:
PMCID: PMC2917770

Collision coupling, crosstalk, and compartmentalization in G-protein coupled receptor systems: Can a single model explain disparate results?


The collision coupling model describes interactions between receptors and G-proteins as first requiring the molecules to find each other by diffusion. A variety of experimental data on G-protein activation have been interpreted as suggesting (or not) the compartmentalization of receptors and/or G-proteins in addition to a collision coupling mechanism. In this work, we use a mathematical model of G-protein activation via collision coupling but without compartmentalization to demonstrate that these disparate observations do not imply the existence of such compartments. In experiments with GTP analogs (commonly GTPγS), the extent of G-protein activation is predicted to be a function of both receptor number and the rate of GTP analog hydrolysis. The sensitivity of G-protein activation to receptor number is shown to be dependent upon the assay used, with the sensitivity of phosphate production assays (GTPase) > GTPγS binding assays > cAMP inhibition assays. Finally, the amount of competition or crosstalk between receptor species activating the same type of G-proteins is predicted to depend on receptor and G-protein number, but in some (common) experimental regimes this dependence is expected to be minimal. Taken together, these observations suggest that the collision coupling model, without compartments of receptors and/or G-proteins, is sufficient to explain a variety of observations in literature data.

Keywords: mathematical model, adrenergic, opioid, cannabinoid, muscarinic


The ability of the G protein-coupled signal transduction system to detect a stimulus depends on interactions between receptors and G-proteins. Such interactions have been described by the collision coupling model (Tolkovsky and Levitzki, 1978), reviewed in Lauffenburger and Linderman (1993), which allows for receptors and G-proteins to diffuse in the membrane and interact if the correct recognition surfaces are present when they collide. When multiple receptor types can activate the same G-proteins, the collision coupling model predicts that there is competition between the receptor types for the same G-protein pool (e.g. (Graeser and Neubig, 1993)). Such competition is one route to what has broadly been termed crosstalk, or the influence of activation of one receptor type on signaling through a second receptor type. In this paper, we explore the predictions of the collision coupling model for crosstalk and comment on the interpretation of experimental data that has been used previously to suggest there is compartmentalization of receptors and G proteins.

Several experimental techniques can be used to measure G-protein activation. Activation of G-proteins can be assayed by measuring binding of the slowly hydrolysable (commonly referred to as “non-hydrolysable”) GTP analogs GTPγS (as [35S]GTPγS) or GppNHp (as [3H]GppNHp) to determine the rate of G-protein activation and the number of active G-proteins at steady state (Harrison and Traynor, 2003). GTPase experiments measure the rate at which GTP is hydrolyzed to GDP; the number of active GTP-bound G-proteins is directly proportional to the rate of phosphate production. Other methods to assess G-protein activation include measurement of downstream players, e.g. cAMP production, and a FRET-based method to detect separation of α and βγ subunits (Azpiazu and Gautam, 2004).

In experiments with a single receptor type, receptor number may be decreased and the maximum level of G-protein activation (the extent of reaction) measured. If the extent of reaction is independent of the receptor concentration, this is commonly interpreted to mean that receptors are free to diffuse on the membrane, i.e. there is no compartmentalization that limits the access of receptors to the full complement of G-proteins. For example, in an early study of the β-adrenergic receptor and adenylyl cyclase (AC) activation in turkey erythrocytes, when the number of receptors was decreased the extent of cAMP production did not change (Tolkovsky and Levitzki, 1978). Fantozzi et al. (1981) made a similar observation that the extent of cAMP inhibition did not change in NG108-15 cells when opioid receptor number was reduced. This insensitivity in cAMP inhibition to changing receptor concentration means there is a receptor reserve (Brown and Goldstein, 1986).

In other reports, however, the amount of G-protein activation is sensitive to receptor number (Costa et al., 1988; Newman-Tancredi et al., 1999; Remmers et al., 2000; Traynor et al., 2002). For example, upon reducing the number of opioid receptors heterologously expressed in digitonin-permeabilized C6 glioma cells, the degree of G-protein activation decreased (Alt et al., 2001). This has been interpreted to mean that here compartmentalization limits the access of receptors to G-proteins, suggesting that dissimilar systems may behave quite differently. Indeed, submicroscopic corrals, which may be formed by actin filaments near the membrane (Ritchie et al., 2005), lipid domains or rafts (Daumas et al., 2003) or by other mechanisms (Saxton, 2005) affect diffusion in the membrane and perhaps could play a role in segregating membrane components.

To further test for compartmentalization of receptors and G-proteins and as a quantitative measure of crosstalk, investigators have used multiple agonists that bind to different receptors but activate the same class of G proteins. If the agonist-occupied receptor species are free to diffuse in the membrane, they will compete for G-proteins, creating crosstalk. Such competition is seen when measuring GTPγS binding in SH-SY5Y (neuroblastoma) cell membranes: activation of both endogenous µ- and δ-opioid receptors results in a maximal level of GTPγS binding equal to activation of just µ-opioid receptors alone (Alt et al., 2002). Similar observations of GTPγS binding are made for δ-opioid and CB1 cannabinoid receptors exogenously expressed in COS-7 cell membranes (Shapira et al., 2000). When measuring Ca2+ current cannabinoid and adrenergic receptors in superior cervical ganglion neurons cells compete to activate G-proteins (Vasquez and Lewis, 1999). Further, measurements of cAMP production after activation of prostaglandin and adrenergic receptors in frog erythrocytes (Pike and Lefkowitz, 1981) and glucagon and adrenergic receptors in rat and hamster adipocytes (Murayama and Ui, 1984) also show that the two receptor types share and compete for a common pool of G-proteins. These results are in agreement with the expectation of receptors freely diffusing on the membrane in a collision coupling model.

However, in other experimental systems receptors that activate the same class of G-proteins do not compete with each other and do not display crosstalk. In NG108-15 (neuroblastoma-glioma) cells, endogenous α-adrenergic, muscarinic and δ-opioid receptors all couple to inhibitory G-proteins but simultaneous activation of opioid and muscarinic receptors shows no crosstalk when measured at the level of agonist affinity (a proxy for G-protein activation) (Graeser and Neubig, 1993). In SK-N-SH cells (a parent cell line of SH-SY5Y cells described above) no crosstalk is observed between endogenous µ- and δ-opioid and cannabinoid receptors for GTPγS binding (Shapira et al., 2000); the activation of both receptor types produces as much GTPγS binding as the sum of the amount produced when each receptor type is activated alone. To explain these results it has been proposed that the different receptor types in these cell systems are to some degree segregated from each other in membrane compartments and compartmentalized with their cognate G-proteins.

Above we have given examples where crosstalk may or may not be present in endogenous systems. We questioned whether these disparate results are the result of different situations, namely systems in which compartmentalization of receptors is present and systems in which it is not, or whether the results could be explained by a single model. We hypothesized that compartmentalization is not necessary to explain the sensitivity of activation to receptor number nor the absence of crosstalk in some systems. To test this hypothesis we used a mathematical model of the G-protein activation cycle under conditions of collision coupling but with no compartmentalization. Key model parameters include the number of cell surface receptors and G-proteins and the rate constant for hydrolysis of GTP or GTP analog. By varying these parameters we are able to explain the range of behaviors seen experimentally without the need to invoke membrane compartments.


Mathematical Model

Our model for the G-protein activation cycle is shown in Fig. 1 and is based on previous models of G-protein activation (Riccobene et al., 1998; Yi et al., 2003; Zhong et al., 2003). Receptors and G-proteins diffuse freely in the membrane and bind with rate constant k+, the value of which depends on the diffusivity of the molecules and the probability that a collision between the two is productive. Thus this model uses a collision coupling mechanism for activation of G proteins by bound receptors. There is no compartmentalization of molecules in the model; receptors and G-proteins are assumed to have free access to each other.

Figure 1
G-protein activation model, based on (Riccobene et al., 1998; Yi et al., 2003; Zhong et al., 2003). Agonist (L) binds to receptor (R) to form an active agonist-receptor complex (LR*) with rate constants kon (M−1s−1) and koff (s−1 ...

The G-protein activation model is described by mass action kinetics with the following differential equations:








Definitions of rate constants are given in Table 1 and species (L, R, LR* etc.) are as defined in Fig. 1. Versions of the model that include the effects of GTPase-activating proteins (GAPs) in a manner similar to Bornheimer et al. (Bornheimer et al., 2004), or that include the very slow dissociation of GTP from free G-protein to leave the “empty” G state (Traynor et al., 2002), predict trends similar to those described in Results (data not shown).

Table 1
Parameter values for the G-protein activation cycle. Reported values of receptor and G-protein concentrations in mol/mg were converted to approximate #/cell (RTOT, GTOT) or mol/volume of solution (used in equations) using the values of 2×109 cells/250 ...

Equations were solved using the NSolve function in Mathematica (Wolfram Research). For each of the three different types of assays simulated a different model output was needed. For simulation of a GTP analog assay the relevant model output is the concentration of analog bound to G-protein, here denoted using the notation GGTP for all analogs (Eqn. 6). For simulation of a GTPase experiment the relevant model output is the concentration of free phosphate as calculated by:


For simulation of a cAMP experiment the relevant model output is the percent inhibition of cAMP production as calculated by:

%inhibition cAMP=Vmax[GGTP]/(KM+[GGTP])

More complex models of cAMP production have been used (Bhalla and Iyengar, 1999; Dougherty et al., 2005), but this simple model provides a sufficient demonstration for our purposes of the role of receptor number and crosstalk in cAMP inhibition.

To approximately characterize the rate and extent of G-protein activation for some cases the time course of G-protein activation (GGTP(t)) was fit using least squares regression to a one-phase association:


where the two fit parameters are GGTP,max and kobs. GGTP,max is the extent of the reaction, or the maximal amount of G-protein that will be bound to GTP at steady state. For clarity, the notation GGTPγS,max will be used for GTPγS binding. kobs is the observed rate constant for activation.

To quantify the amount of crosstalk between two receptor types (R1 and R2), we compute the activation produced by binding each receptor type alone (R1 and R2) and that produced by binding both receptors simultaneously (R1+2) and then calculate:


The maximum amount of competition (100 %) occurs when adding a second receptor type produces no additional G-protein activation. When the receptors do not compete the amount of activation produced by binding both receptors is equal to the sum of that produced by each receptor alone and the % competition is 0%.

Parameter values

Parameter values used in the simulations are given in Table 1 and are similar to those reported by Zhong et al. (Zhong et al., 2003) for α2a-adrenergic receptors in CHO cells. The rate constant for coupling between receptors and G-proteins, k+, depends on the concentrations of G-protein and receptor and the diffusion coefficient, D, and was estimated by:


where s is the interaction radius of a receptor and G-protein and SA is the surface area of the cell membrane (Lauffenburger and Linderman, 1993); we used D=10−10 cm2/sec, s = 10 nm, SA = 1400 µm2. The concentration of the GDP-bound heterotrimeric G-protein (GGDP) is a function of time and the model recalculates the value of b at each time step based on the concentration of GGDP at that time. Improved estimates of k+ can be obtained from Monte Carlo simulations of receptor and G-protein diffusion and collision in the membrane (Shea et al. 1997; Shea and Linderman, 1998), but those do not affect the conclusions drawn here.

The value of the rate constant for GTP hydrolysis, khyd, was taken from Zhong et al. (Zhong et al., 2003) and Mukhopadhyay and Ross (Mukhopadhyay and Ross, 1999). The GTP analogs GTPγS and GppNHp are commonly termed non-hydrolysable because of their long half-life, but they are in fact slowly hydrolyzed. Ott and Costa (Ott and Costa, 1989) measured GTP analog half-life (t1/2) for GTPγS and GppNHp. Assuming a first order process, these lifetimes can be converted to hydrolysis rate constants according to:


Numbers of receptors and G-proteins per cell may vary widely between cell lines and between tranfected and endogenous systems. Values used here are estimated from available data and are useful in demonstrating trends and qualitative agreement of model and data; more measurements of these key parameters are needed for quantitative testing.

Results and Discussion

With our model of G-protein activation we simulate three types of assays that measure G-protein activation: GTPγS binding, phosphate production from GTP (GTPase), and inhibition of cAMP.

GTP analog hydrolysis has a major impact on the extent of reaction

We consider first experiments in which the GTP analog GTPγS is used to monitor G-protein activation. We use our model describing free access of receptor and G-protein (Fig. 1) to predict the amount of GTPγS bound when the GTP hydrolysis rate constant (khyd) is zero, the common assumption when using the “non-hydrolyzable” GTP analog GTPγS. In this case, the model predicts that changes in receptor number change the observed rate constant for the reaction but not the maximal amount of binding (GGTPγS,max) (Fig. 2A). For the parameter values used (Table 1; khyd = 0; total concentration of GTPγS = 0.05 nM), GGTPγS,max is 0.05 nM for all receptor concentrations but kobs increases from 0.003/min at the lowest receptor concentration (RTOT = 2×104/cell) to 0.027/min at the highest receptor concentration (RTOT = 4×105/cell). The observed overall rate constant kobs increases with receptor number because it is the product of the intrinsic rate constant and the concentrations of agonist-bound receptors and G-proteins. For the parameter values used here, G-protein activation reaches a steady state when the limiting reagent GTPγS is consumed; a higher concentration of GTPγS will label more G-proteins in both the model and in experiments (Remmers et al., 2000). These model predictions conflict with the observation in many systems that the extent of reaction decreases with decreasing receptor number (Graeser and Neubig, 1993; Remmers et al., 2000; Alt et al., 2001; Traynor et al., 2002), suggesting that the collision coupling model as formulated here is incorrect.

Figure 2
GTPγs binding for different numbers of receptors. A) Model predictions with no GTPγS hydrolysis (khyd = 0) and total receptor number RTOT varied from 2×104 – 4×105/cell. For all receptor numbers, the maximum degree ...

However, the rate constant for GTPγS hydrolysis is not zero and in fact has a low but measurable value (Table 1). With our model we next calculate the effect of using the slow measured rate constant of GTPγS hydrolysis to observe the impact hydrolysis has on the extent of reaction, using experimental values for receptor number from Alt et al. (2001). As shown in Fig. 2B, both the maximal amount of GTPγS bound (GGTPγS,max) and the overall observed rate constant for the reaction (kobs) increase with increasing receptor number. For comparison on the same plot are the experimental data of Alt et al. (Alt et al., 2001) showing the effect of opioid receptor number on G-protein activation.

The simulation result of Fig. 2B is different – both qualitatively and quantitatively - from that of Fig. 2A because the structure of the reaction network is changed. When the hydrolysis rate constant (khyd) is set to zero, and because GTPγS is present in low concentrations but has a high affinity for LR*G0, the simulation shows that essentially all GTPγS ultimately becomes bound to G protein regardless of the receptor number, although the rate at which it all becomes bound does depend on receptor number. However, when the hydrolysis rate constant is non-zero, an additional pathway, the hydrolysis reaction, acts to remove bound GTPγS from the system. The plateau in bound GTPγS reached in Fig. 2B reflects a balance in the rates of receptor and G protein association (which, as in the previous case, is a function of receptor number) and GTPγS dissociation and hydrolysis (Traynor et al. 2002; Breivogel et al. 1998)1. Thus when GTP analog hydrolysis is included, the collision coupled model (Fig. 1) can account for the decrease in extent of G-protein activation due to decreased receptor number and it is not necessary to postulate the existence of compartments to explain the experimental data.

The maximum degree of G-protein analog binding that occurs depends on the GTP analog hydrolysis rate constant (Fig. 3). As the hydrolysis rate constant increases (or the analog lifetime decreases), the maximum degree of G-protein analog binding decreases. To test this prediction, one might use the GTP analog GppNHp, which has a hydrolysis rate constant intermediate between that of GTPγS and GTP. For example, for the conditions used in Fig. 3 (and representative of a GTPγS experiment) the maximum degree of GppNHp binding is predicted to be approximately two-thirds that which would be obtained using GTPγS. The maximum degree of binding by a G-protein analog that could not be hydrolyzed would be limited by the concentration of G-protein analog, and varying receptor number would vary the observed rate constant kobs but not the maximum degree of binding (recall Fig 2A).

Figure 3
Extent of GTP analog binding and the GTP analog hydrolysis rate constant. The hydrolysis rate constant khyd (value indicated for each analog by a vertical line under the analog name) is inversely related to the analog lifetime. Increasing GTP analog lifetime ...

Sensitivity of G protein activation to receptor number depends on the assay used

In Figs. 2 and and3,3, we examined the predictions of the collision coupled model when a GTP analog is used to monitor G protein activation. We now turn to experiments that quantify G-protein activation in other ways. We model the production of phosphate from hydrolysis of GTP to GDP as a function of time and in Fig. 4A show strong agreement between simulation results (solid line) and experimental data from Clark et al. (2003). The model can also reproduce the inhibition of cAMP production by AC over a range of concentrations of the µ-opioid agonist DAMGO (Fig. 4B) seen in a variety of different systems (Carter and Medzihradsky, 1993; Liu and Prather, 2001; Gharagozlou et al., 2003; Mandyam et al., 2003; Clark and Traynor, 2005).

Figure 4
Model predictions for phosphate production (GTPase assay) and inhibition of cAMP. A) Phosphate production for RTOT = 7×105/cell. Experimental data of Clark et al. (2003) are shown as points and simulation results are shown as a smooth curve. Both ...

Thus our model can be used in appropriate form to represent G-protein activation as assayed by GTP analogs, phosphate production, or cAMP production. We are now able to predict and compare the impact of receptor concentration on G-protein activation in each of the three assays for a constant G-protein concentration. In Fig. 3 we show that although in general increasing receptor number leads to an increase in the maximal response (GGTPγS,max), increasing receptor number beyond ~ 5×105 receptors/cell gives only a marginal increase in GGTPγS,max. Similarly, in Figs. 4C and D the effect of receptor number on the rate of phosphate production and on percent inhibition of cAMP production are shown. In these assays, too, increasing receptor number increases the response but once a high enough receptor number is reached the effect saturates. For assays of the rate of phosphate production 90% of the maximum (dashed line) occurs ~ 6×106 receptors/cell; for assays of inhibition of cAMP production 90% of the maximum (dashed line) occurs ~ 1×105 receptors/cell.

These results suggest that the degree of dependence of G-protein activation on receptor number depends on the assay used; for example, a greater dependence might be observed in GTP analog assays than in cAMP assays. Indeed, this is the case. Data showing a sensitivity of G-protein activation to receptor number have been reported from many GTP analog assays, as described above (Remmers et al., 2000; Alt et al., 2001; Traynor et al., 2002). Yet data showing no dependence of G-protein activation on receptor number have also been reported from cAMP assays (Tolkovsky and Levitzki, 1978; Fantozzi et al., 1981). Because the dependence on receptor number saturates at different receptor numbers for the different assays, these reports are all consistent with the collision coupled model (i.e. with no compartmentalization). In other words, spare receptors or a receptor reserve might be observed in a particular system (with a particular receptor number) for cAMP production but not GTPγS binding.

Receptor and G-protein concentrations influence receptor crosstalk

An implication of the collision coupled model is that receptor types which activate the same class of G-proteins will compete for those G-proteins, giving rise to crosstalk. On the other hand, if there are compartments such that not all G-proteins are accessible to a particular receptor type, then there will be reduced (or no) competition or crosstalk. With our model we simulate GTPγS binding or phosphate production from GTP and compare levels of activation produced by agonists binding to two receptor types with activation produced by each of those agonists alone. If there is no competition for G-proteins, activation for the pair experiment will be the same as the sum of the activation caused by the individual receptors alone. If there is competition, activation found for the pair experiment will be less than the sum. As shown in Fig. 5A and B, both behaviors are seen in experimental data in various systems (Shapiro et al., 2000).

Figure 5
Competitive and non-competitive (additive) behavior seen in multiple agonist experiments. A) CB-1 Cannabinoid and µ-opioid receptors in COS-7 cells compete for G-proteins in a GTPγS assay (Shapira et al., 2000). B) µ and δ-opioid ...

Simulations of GTPγS binding via two receptors show both competitive and non-competitive behavior depending on the receptor concentrations (Fig. 5C,D). Receptor concentrations used are an approximation of measured values for opioid receptors in cells endogenously expressing opioid receptors or heterologously transfected with opioid receptors. The transfected cell has a high receptor concentration and the endogenous receptor concentration is many orders of magnitude smaller (Shapira et al., 2001). At a high receptor concentration (2×106/cell each of R1 and R2) the receptors compete for G-proteins. Both agonists together activate nearly the same number of G-proteins as one agonist alone and much less than the sum of the responses to both agonists if delivered individually. At a low receptor concentration (2×104/cell of each R1 and R2) the activation by both agonists together is nearly the sum of that produced by each receptor type alone. A similar dependence on total receptor number occurs when G-protein activation is measured in a GTPase experiment (Fig 5E, F). These results are in agreement with FRET data with tagged muscarinic receptors expressed in CHO cells that show for lower receptor concentrations multiple receptor types don’t compete for G-proteins but when one receptor type is overexpressed there is competition (Azpiazu and Gautam, 2004).

Whether competition or crosstalk is seen may also depend on G-protein concentration. Graeser and Neubig (1993) report non-competitive behavior for a G-protein concentration estimated to be on the order of 7.5×105/cell and a total receptor concentration of 7.5×104/cell (a combination of α2 adrenergic, muscarinic and δ-opioid receptors) in NG108-15 cells. For these conditions our simulations predict competition is minimal (Fig. 6). Graeser and Neubig then significantly reduced the G-protein concentration but the receptors were still not competitive, leading to their suggestion of membrane compartments segregating G-proteins and receptors. Shapira et al. (2000) also observed that a significant reduction in G-protein concentration in some cases does not create competition.

Figure 6
Crosstalk depends in part on both receptor and G-protein concentrations. A) Predicted % competition (Eqn. 11) for a range of total receptor (R1 + R2) and G-protein concentrations. G-protein activation is simulated via the GTPγS assay. Predicted ...

In our model for a high number of G-proteins and a low number of receptors (bottom right quadrant of Fig. 6) a change in G-protein concentration has only a minimal effect on the predicted amount of competition. But, for a low number of G-proteins and a high number of receptors (top left quadrant of Fig. 6) competition between receptors is significant. In general competition is more sensitive to receptor number than G-protein number (contours in Fig. 6 are much steeper changing RTOT than GTOT). To allow a comparison with the results of Graeser and Neubig (1993), we ran simulations at RTOT = 7.5×104/cell and GTOT = 7.5×104/cell or 7.5×105/cell. The results of these two conditions are shown in Fig. 6. At the higher G-protein number, both receptor types produce G-protein activation nearly equal to the sum of both receptor types alone (17% competitive). At the lower G-protein number, both receptor types activate almost the same relative amount of G-proteins (27% competitive). The difference between 17 and 27% competitive is likely below the detection threshold of the experimental assay. Thus, an explanation for the lack of crosstalk or competition among receptor types for the parameters tested here does not need to invoke compartmentalization of receptors.


In this work we demonstrate using a mathematical model of collision coupling that compartmentalization of receptors and/or G-proteins within the membrane is not necessary to explain literature data on the extent of G-protein activation and receptor crosstalk. First, we show that the slow hydrolysis rate of GTPγS, a GTP analog commonly termed “non-hydrolyzable”, plays an important role in determining the extent of G-protein activation. We predict that two different GTP analogs tested in the same experimental system will produce different extents of G-protein activation because they have different rates of hydrolysis (Fig. 3). Second, the dependence of G-protein activation on receptor number is shown to be assay-dependent, with the sensitivity of phosphate production assays (GTPase assay) > GTPγS binding assay > cAMP inhibition assay (Figs. 3,,4).4). Finally, we find that the number of receptors and G-proteins available affects receptor crosstalk in a nonlinear fashion (Fig. 6). Thus upregulation, internalization, or desensitization of receptors and G-proteins that occur on agonist occupancy of receptors will influence the extent of cross talk in vivo and might be used experimentally to influence the extent of crosstalk in a particular system.

In developing models of G-protein activation, our ultimate goal is to enable quantitative hypothesis testing of signaling mechanisms. Experimental examination of signaling processes at different spatial and temporal scales, for example the motion of individual molecules or the formation of particular signaling complexes, may require a more detailed model than that used here. Indeed, mechanisms other than variation in receptor or G-protein number, including the formation of multi-protein signaling complexes, clustering of receptors via dimerization or regulation of the numbers of other signaling proteins, may play roles in regulating crosstalk (Hall and Lefkowitz, 2002; Breitwieser, 2004; Woolf and Linderman, 2004; Desai et al., 2006). While we found it was not necessary to incorporate compartments to explain the signaling data explored here, compzartments may indeed exist and play a role at other levels. In recent years, there have been several reports of anomalous diffusion of proteins in the cell membrane which may be the result of membrane compartments (Daumas et al., 2003; Ritchie et al., 2005; Saxton, 2005). Membrane compartments may also have important role in initiating the formation of signaling complexes (Barnett-Norris et al., 2005). Future work may elucidate the roles that these various phenomena play in signaling.


We thank Mary J. Clark for helpful discussions and C. Perrin for assistance with calculations. This work was supported by Merck Research Laboratories, NIH R01 GM 062930 and DA04087.


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

1Assuming GTPγS present in excess.


  • Alt A, Clark MJ, Woods JH, Traynor JR. Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells. Br J Pharmacol. 2002;135(1):217–225. [PMC free article] [PubMed]
  • Alt A, McFadyen IJ, Fan CD, Woods JH, Traynor JR. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein. J Pharmacol Exp Ther. 2001;298(1):116–121. [PubMed]
  • Azpiazu I, Gautam N. A fluorescence resonance energy transfer-based sensor indicates that receptor access to a G protein is unrestricted in a living mammalian cell. J Biol Chem. 2004;279(26):27709–27718. [PubMed]
  • Barnett-Norris J, Lynch D, Reggio PH. Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system. Life Sci. 2005;77(14):1625–1639. [PubMed]
  • Bhalla US, Iyengar R. Emergent properties of networks of biological signaling pathways. Science. 1999;283(5400):381–387. [PubMed]
  • Bornheimer SJ, Maurya MR, Farquhar MG, Subramaniam S. Computational modeling reveals how interplay between components of a GTPase-cycle module regulates signal transduction. Proc Natl Acad Sci U S A. 2004;101(45):15899–15904. [PubMed]
  • Breitwieser GE. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. Circ Res. 2004;94(1):17–27. [PubMed]
  • Breivogel CS, Selley DE, Childers SR. Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J Biol Chem. 1998;273(27):16865–16873. [PubMed]
  • Brown JH, Goldstein D. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells. Mol Pharmacol. 1986;30(6):566–570. [PubMed]
  • Carter BD, Medzihradsky F. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain. Proc Natl Acad Sci U S A. 1993;90(9):4062–4066. [PubMed]
  • Clark MJ, Harrison C, Zhong H, Neubig RR, Traynor JR. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways. J Biol Chem. 2003;278(11):9418–9425. [PubMed]
  • Clark MJ, Traynor JR. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells. J Pharmacol Exp Ther. 2005;312(2):809–815. [PubMed]
  • Costa T, Klinz FJ, Vachon L, Herz A. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. Mol Pharmacol. 1988;34(6):744–754. [PubMed]
  • Daumas F, Destainville N, Millot C, Lopez A, Dean D, Salome L. Confined diffusion without fences of a g-protein-coupled receptor as revealed by single particle tracking. Biophys J. 2003;84(1):356–366. [PubMed]
  • Desai AN, Salim S, Standifer KM, Eikenburg DC. Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the alpha2B-adrenoceptor. J Pharmacol Exp Ther. 2006;317(3):1027–1035. [PubMed]
  • Dougherty DP, Wright GA, Yew AC. Computational model of the cAMP-mediated sensory response and calcium-dependent adaptation in vertebrate olfactory receptor neurons. Proc Natl Acad Sci U S A. 2005;102(30):10415–10420. [PubMed]
  • Fantozzi R, Mullikin-Kilpatrick D, Blume AJ. Irreversible inactivation of the opiate receptors in the neuroblastoma x glioma hybrid NG108-15 by chlornaltrexamine. Mol Pharmacol. 1981;20(1):8–15. [PubMed]
  • Gharagozlou P, Demirci H, David Clark J, Lameh J. Activity of opioid ligands in cells expressing cloned mu opioid receptors. BMC Pharmacol. 2003;3:1. [PMC free article] [PubMed]
  • Graeser D, Neubig RR. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors. Mol Pharmacol. 1993;43(3):434–443. [PubMed]
  • Hall RA, Lefkowitz RJ. Regulation of G protein-coupled receptor signaling by scaffold proteins. Circ Res. 2002;91(8):672–680. [PubMed]
  • Harrison C, Traynor JR. The [35S]GTPgammaS binding assay: approaches and applications in pharmacology. Life Sci. 2003;74(4):489–508. [PubMed]
  • Holmes JL, Pollenz RS. Determination of aryl hydrocarbon receptor nuclear translocator protein concentration and subcellular localization in hepatic and nonhepatic cell culture lines: development of quantitative Western blotting protocols for calculation of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein in total cell lysates. Mol Pharmacol. 1997;52(2):202–211. [PubMed]
  • Kenakin T. Pharmacologic Analysis of Drug-Receptor Interaction. New York: Raven Press, Ltd.; 1993.
  • Lauffenburger D, Linderman JJ. Receptors: Models for Binding, Trafficking, and Signaling. New York: Oxford University Press; 1993.
  • Liu JG, Prather PL. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Mol Pharmacol. 2001;60(1):53–62. [PubMed]
  • Mandyam CD, Thakker DR, Standifer KM. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity. J Pharmacol Exp Ther. 2003;306(3):965–972. [PubMed]
  • Mukhopadhyay S, Ross EM. Rapid GTP binding and hydrolysis by G(q) promoted by receptor and GTPase-activating proteins. Proc Natl Acad Sci U S A. 1999;96(17):9539–9544. [PubMed]
  • Murayama T, Ui M. [3H]GDP release from rat and hamster adipocyte membranes independently linked to receptors involved in activation or inhibition of adenylate cyclase. Differential susceptibility to two bacterial toxins. J Biol Chem. 1984;259(2):761–769. [PubMed]
  • Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. Mol Pharmacol. 1999;55(3):564–574. [PubMed]
  • Ott S, Costa T. Enzymatic degradation of GTP and its "stable" analogues produce apparent isomerization of opioid receptors. J Recept Res. 1989;9(1):43–64. [PubMed]
  • Pike LJ, Lefkowitz RJ. Correlation of beta-adrenergic receptor-stimulated [3H]GDP release and adenylate cyclase activation. Differences between frog and turkey erythrocyte membranes. J Biol Chem. 1981;256(5):2207–2212. [PubMed]
  • Remmers AE, Clark MJ, Alt A, Medzihradsky F, Woods JH, Traynor JR. Activation of G protein by opioid receptors: role of receptor number and G-protein concentration. Eur J Pharmacol. 2000;396(2–3):67–75. [PubMed]
  • Riccobene TA, Waller A, Hoffman JF, Linderman JJ, Omann GM. Threshold and graded response behavior in human neutrophils: effect of varying G-protein or ligand concentrations. Biochemistry. 1998;37(33):11534–11543. [PubMed]
  • Ritchie K, Shan XY, Kondo J, Iwasawa K, Fujiwara T, Kusumi A. Detection of non-Brownian diffusion in the cell membrane in single molecule tracking. Biophys J. 2005;88(3):2266–2277. [PubMed]
  • Sarvazyan NA, Lim WK, Neubig RR. Fluorescence analysis of receptor-G protein interactions in cell membranes. Biochemistry. 2002;41(42):12858–12867. [PubMed]
  • Saxton MJ. Fluorescence correlation spectroscopy. Biophys J. 2005;89(6):3678–3679. [PubMed]
  • Shapira M, Keren O, Gafni M, Sarne Y. Divers pathways mediate delta-opioid receptor down regulation within the same cell. Brain Res Mol Brain Res. 2001;96(1–2):142–150. [PubMed]
  • Shapira M, Vogel Z, Sarne Y. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors. Cell Mol Neurobiol. 2000;20(3):291–304. [PubMed]
  • Shea LD, Linderman JJ. Compartmentalization of receptors and enzymes affects activation for a collision coupling mechanism. Journal of Theoretical Biology. 1998;191(3):249–258.
  • Shea LD, Omann GM, Linderman JJ. Calculation of diffusion-limited kinetics for the reactions in collision coupling and receptor cross-linking. Biophys J. 1997;73(6):2949–2959. [PubMed]
  • Stickle D, Barber R. Estimation of the kinetic constants for binding of epinephrine to beta-adrenergic receptors of the S49 cell. Biochem Pharmacol. 1991;42(5):1069–1077. [PubMed]
  • Thomsen WJ, Neubig RR. Rapid kinetics of alpha 2-adrenergic inhibition of adenylate cyclase. Evidence for a distal rate-limiting step. Biochemistry. 1989;28(22):8778–8786. [PubMed]
  • Tolkovsky AM, Levitzki A. Mode of coupling between the beta-adrenergic receptor and adenylate cyclase in turkey erythrocytes. Biochemistry. 1978;17(18):3795. [PubMed]
  • Traynor JR, Clark MJ, Remmers AE. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists. J Pharmacol Exp Ther. 2002;300(1):157–161. [PubMed]
  • Vasquez C, Lewis DL. The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors. J Neurosci. 1999;19(21):9271–9280. [PubMed]
  • Woolf PJ, Linderman JJ. An algebra of dimerization and its implications for G-protein coupled receptor signaling. J Theor Biol. 2004;229(2):157–168. [PubMed]
  • Yi TM, Kitano H, Simon MI. A quantitative characterization of the yeast heterotrimeric G protein cycle. Proc Natl Acad Sci U S A. 2003;100(19):10764–10769. [PubMed]
  • Zhong H, Wade SM, Woolf PJ, Linderman JJ, Traynor JR, Neubig RR. A spatial focusing model for G protein signals. Regulator of G protein signaling (RGS) protien-mediated kinetic scaffolding. J Biol Chem. 2003;278(9):7278–7284. [PubMed]